文献速递慢性肾脏病遗传性与小管间质肾病血液净化与透析

儿童慢性肾脏病骨评估:ESPN与ERA-EDTA临床实践要点

Bone evaluation in paediatric chronic kidney disease: clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

欧洲儿童肾脏病学会CKD-MBD与透析工作组及ERA-EDTA CKD-MBD工作组基于现有最佳证据与专家共识,提出儿童CKD 2-5期及透析患者骨病评估的临床实践要点。骨活检是金标准但有创且昂贵,双能X线吸收法及骨形成/吸收标志物受生长和青春期影响,敏感性与特异性有限。实践要点供临床医生个体化参考。

要点

  • 儿童CKD-MBD普遍且致残,需关注骨重塑/塑形异常。
  • 骨活检为金标准,但有创、昂贵且需专业解读。
  • 双能X线吸收法与骨标志物受生长和青春期影响,预测价值有限。

核心结论

  • 儿童CKD-MBD普遍且与显著发病率相关,骨评估是临床护理关键但挑战大。
  • 现有非侵入性骨评估方法受生长和青春期影响,敏感性与特异性有限。
  • 实践要点基于最佳证据与专家共识,应个体化应用并建议进一步研究。

研究设计与样本

  • 由欧洲儿童肾脏病学会CKD-MBD与透析工作组及ERA-EDTA CKD-MBD工作组制定临床实践要点。
  • 基于现有最佳证据与专家共识,针对儿童CKD 2-5期及透析患者骨病评估。

主要发现

  • 儿童CKD可致骨重塑/塑形异常,表现为矮身材、骨痛、畸形、骨折、滑脱骨骺和异位钙化。
  • 骨活检组织形态计量学是评估骨健康的金标准,但昂贵、有创且需专业解读。
  • 双能X线吸收法和骨形成/吸收标志物受生长和青春期状态影响,预测骨转换和矿化变化的敏感性与特异性有限。

临床怎么用

  • 临床医生应仔细考虑实践要点并酌情个体化调整。
  • 在缺乏高质量证据下,儿童CKD-MBD诊断与管理临床实践差异大。
  • 建议进一步研究以填补证据空白。

局限性

  • 缺乏高质量证据,实践要点基于专家共识。
  • 骨活检金标准有创且需专业解读,非侵入性方法敏感性与特异性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mineral and bone disorder (MBD) is widely prevalent in children with chronic kidney disease (CKD) and is associated with significant morbidity. CKD may cause disturbances in bone remodelling/modelling, which are more pronounced in the growing skeleton, manifesting as short stature, bone pain and deformities, fractures, slipped epiphyses and ectopic calcifications. Although assessment of bone health is a key element in the clinical care of children with CKD, it remains a major challenge for physicians. On the one hand, bone biopsy with histomorphometry is the gold standard for assessing bone health, but it is expensive, invasive and requires expertise in the interpretation of bone histology. On the other hand, currently available non-invasive measures, including dual-energy X-ray absorptiometry and biomarkers of bone formation/resorption, are affected by growth and pubertal status and have limited sensitivity and specificity in predicting changes in bone turnover and mineralization. In the absence of high-quality evidence, there are wide variations in clinical practice in the diagnosis and management of CKD-MBD in childhood. We present clinical practice points (CPPs) on the assessment of bone disease in children with CKD Stages 2-5 and on dialysis based on the best available evidence and consensus of experts from the CKD-MBD and Dialysis working groups of the European Society for Paediatric Nephrology and the CKD-MBD working group of the European Renal Association-European Dialysis and Transplant Association. These CPPs should be carefully considered by treating physicians and adapted to individual patients' needs as appropriate. Further areas for research are suggested.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Bakkaloglu SA, Bacchetta J, Lalayiannis AD, et al. Bone evaluation in paediatric chronic kidney disease: clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA. Nephrol Dial Transplant. 2021. PMID: 33245331. doi:10.1093/ndt/gfaa210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。